Source:http://linkedlifedata.com/resource/pubmed/id/17909198
J. Clin. Oncol. 2007 Dec 1 25 34 5471-89
General Info
Affiliation
Department of Medicine E, Rabin Medical Center, Petah-Tiqva, Israel. Eyalr2@clalit.org.ilAbstract
To evaluate the effect of antifungal prophylaxis on all-cause mortality as primary outcome, invasive fungal infections (IFIs), and adverse events. Many studies have evaluated the role of antifungal prophylaxis in cancer patients, with inconsistent conclusions.
PMID
17909198